Ivantis Stock

ivantisinc.comHealthcare / Other HealthcareFounded: 1900Funding to Date: $132.88MM

lvantis is a healthcare company committed to expanding patient treatment and improving outcomes through new and innovative minimally invasive glaucoma surgical (MIGS) solutions, the fastest growing segment of the ophthalmology market.

Register To Buy and Sell Shares

For more details on financing and valuation for Ivantis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Ivantis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Ivantis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Dave Van Meter
Chairman, President & Chief Executive Officer
Brandon Lorry
Senior Director
Kenneth Galt
Vice President, Research & Development
Brett Trauthen
Chief Scientific Officer

Board Members

Ben Gust
GBS Venture Partners
Albert Graf
New Enterprise Associates
Lincoln Chee Wang Jin
Randy Alexander
Brant Heise
MemorialCare Innovation Fund
Dave Van Meter
James Pade
Tara Butler MD
Ascension Ventures
Yoh-Chie Lu
Vertex Ventures HC
Ali Behbahani MD
New Enterprise Associates
Douglas Roeder
Delphi Ventures
John Nehra
New Enterprise Associates
Peter Kolchinsky Ph.D
RA Capital Management
Thong Yuen Poon Ph.D
EDBI

Frequently Asked Questions About Ivantis’ Stock

plusminus
Can you buy Ivantis’ stock?
Ivantis is not publicly traded on NYSE or NASDAQ in the U.S. To buy Ivantis’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Ivantis’ stock?
Yes, you can sell stock of a private company like Ivantis. Forge can help you sell your Ivantis stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Ivantis’ stock price?
Ivantis is a privately held company and therefore does not have a public stock price. However, you may access Ivantis’ private market stock price with Forge Data.
plusminus
What is Ivantis’ stock ticker symbol?
Ivantis does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Ivantis Raises $25M in Series C Funding |FinSMEs
Ivantis Inc., an Irvine, CA-based developer of a device designed to lower eye pressure for glaucoma patients, closed a $25m Series C financing. The round was led by new investor RA Capital Management, with participation from new investor Mérieux Développement, as well as existing investors. The company intends to use the funds for US commercialization …
Updated on: Apr 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.